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ABSTRACT: To investigate the effects of aluminum chloride (AlCl3) in the deviation of tissue lipid profiles and 
ways to reduce its effect using antioxidant vitamins C and E, thirty-six male albino rats (120-150g) were divided into 
six groups with six rats each. Group (1) received normal saline and served as control, Group (2) was administered 
with AlCl3 (20mg/kg body weight b.wt)), Group (3) was administered with vitamin C (200mg/kg b.wt), Group (4) was 
administered with vitamin E (200mg/kg b.wt), Groups (5) and (6) were administered aluminium (20mg/kg b.wt) along 
with vitamins C and E (200mg/kg b.wt) respectively. At the end of the experiment, blood samples and organs (liver, 
testis, heart, kidney and brain) were harvested and used for lipid profile determination. The results showed that oral 
administration of aluminum significantly (p<0.05) increased cholesterol level in plasma and VLDL+LDL and 
significantly decreased in erythrocyte, HDL and testis. Cholesterogenesis was induced in the brain, liver, kidney and 
heart. Plasma and VLDL+LDL triglyceride were significantly (p<0.05) increased while erythrocyte and brain 
triglyceride were significantly decreased. Plasma, VLDL+LDL and brain phospholipid levels were significantly 
(p<0.05) decreased and that of erythrocyte significantly increased. There was no significant difference (p>0.05) in 
rats supplemented with vitamin C and vitamin E compared with control. The vitamins significantly attenuated the 
affected lipid levels in the tissues affected. It was concluded that administration of vitamin C and vitamin E 
supplements may be used as therapies against the effects of Aluminium exposure on lipids. 
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INTRODUCTION 
In past years, there has been an increased interest on 
Aluminium (Al) and health. Al is ubiquitous in the environment 
and its widespread use has provoked an interest in its 
toxicity. Al is usually deposited naturally into the environment 
either by weathering and erosion or from anthropogenic 
sources and thus human are frequently exposed to Al by the 
inhalation of ambient air and the ingestion of food and 
medications and water (Soni et al., 2001; Fatima et al., 2001; 
Yokel and McNamara, 2001).  
High level of Al in diet has led to an increase in the deposition 
of this metal in tissues such as heart, kidneys, brain and liver 
which may lead to cardiotoxicity, nephrotoxicity, neutrotoxicity 
and hepatic dysfunctions (Oteiza et al., 1993; Chinoy and 
Patel, 1999; Reinke et al., 2003; Al-Demerdash, 2004).  
Al is suggested to be involved in the pathogenesis of 
neurodegenerative diseases like Alzheimer’s and Parkinson’s 
diseases (Erasmus et al., 1995; Flaten et al., 2001; John et 
al., 2015). Al toxicity can lead to Reactive Oxygen species 
(ROS) formation (Bondy et al., 1998) and can also lead to 
oxidative damage of membrane lipids, proteins and DNA 
(Shohda et al., 2001; Gonzalez et al., 2007; Newairy et al., 
2009). The generation of these ROS have been related to 
diseases such as atherosclerosis, inflammatory conditions, 
neurodegenerative diseases, cancer, diabetes mellitus, renal, 
pulmonary, cardiac diseases and the process of aging 
(Young and Woodside, 2001). Experimental animals that are 
exposed to AI have developed among many dysfunctions, 
lipid dystrophy (El-Demerdash,, 2004; John et al., 2015).  
The use of antioxidants such as vitamins E and C, coenzyme 
Q, glutathione and selenium ions have been used to prevent 
lipid peroxidation and cell damage by acting synergistically 
(Escott-Stump and Mahan 2000). Vitamin C is an effective 
antioxidant owing to its high electron donating power and its 
ability to readily convert back to its reduced form (Devesh et 
al., 2013). It has been reported to play a role in the 
amelioration of some heavy metal toxicity (Onunkwor et al., 
2004; Ugbaja et al., 2013a). Vitamin E (ά- Tocopherol and its 
derivatives) a potent antioxidant has been found to scavenge 
lipid peroxyl radical with formation of tocopheroxyl radical 
thereby inhibiting peroxidation of membrane lipid (Arita et al., 
1998). It enhances immunity by maintaining the functional 
and structural integrity of membranes and immune cells (El-
Demerdash, 2004). 
Several studies on this metal have been done but the 
exposure has been interperitoneal and the major routes of 
human exposure to aluminium are actually pulmonary and 
orally (Testolin et al., 1996). In view of this, the present study 
investigated the effects of orally administered AI as 
Aluminium Chloride on lipid profiles of tissues and 
determined the attenuating properties of vitamin C and 
vitamin E on aluminum toxicity in rats. 
MATERIALS AND METHODS 
Experimental design 
Thirty-six adult male albino rats (Wistar strain) weighing 
between 120-150g and divided into six groups (n=6) were 
used for the study. They were obtained from the Department 
of Anatomy, Faculty of Veterinary Medicine, University of 
Ibadan, Nigeria. The animals were kept housed under 
standard conditions of temperature and natural light-dark 
cycle. All the animals had access to feed and clean water ad 
libitum and all conditions of animal experimentation 
conformed to the NIH guidelines as outlined in NIH 
publication 80-23 (NRC, 1985). They were allowed two 
weeks for acclimation prior to experimental treatment. 
The rats were divided into six groups and were given all oral 
administration of the repective treatments. The duration of 
experiment was 28 days. 
Group 1 – Control (administered normal saline based on 
weight of animal) 
Group 2 – Aluminum Chloride (AlCl3) (20 mg/kg body weight 
(BW)) 
Group 3 – Vitamin C (200 mg/kg BW) 
Group 4 – Vitamin E (200 mg/kg BW) 
Group 5 – AlCl3 (20 mg/kg BW) + Vitamin C (200 mg/kg BW) 
Group 6 – AlCl3 (20 mg/kg BW) + Vitamin E (200 mg/kg BW) 
 
Blood and organ collection 
After twenty-eight days, animals were mildly anaesthetized 
with diethyl ether and the blood samples were collected with 
syringes containing heparin into heparinized tubes. Blood 
samples were separated into plasma and RBC and stored in 
Eppendorf tubes for further analyses while the RBC were 
washed thrice with ice-cold physiological saline solution 
before using for analysis. The brain, heart, testis, kidney and 
liver were excised, trimmed of connective tissues and rinsed 
in ice-cold physiological saline solution. They were then 
blotted dry and 0.2g of each was weighed out and stored at -
20 oC until analyzed.  
Plasma and lipoprotein lipid profiles 
The plasma concentrations of total cholesterol and 
triglyceride were determined by spectrophotometric methods 
using Cypress diagnostic kits. HDL cholesterol and 
triglyceride were determined in plasma with the same 
diagnostic kits for total cholesterol and triglyceride after Very 
Low Density Lipoproteins and Low Density Lipoproteins 
(VLDL+LDL) were precipitated using the method described 
by Gidez et al. (1982).  
For cholesterol, the method is based on the enzymatic 
hydrolysis of cholesteryl esters to cholesterol and fatty acids 
by cholesterol esterase. Cholesterol oxidase then oxidizes 
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cholesterol to produce hydrogen peroxide which condenses 
with phenol in a reaction catalysed by peroxidase. In the 
presence of the former and 4-animoantipyrine, a 
quinoneimine dye is formed which is proportional to the 
concentration of cholesterol in the sample.  
For triglyceride, the method is based on the enzymatic 
hydrolysis of triglyceride to glycerol and free fatty acids by 
lipoprotein lipase. The glycerol is phosphorylated by 
adenosine triphosphate in the presence of glycerol kinase to 
form glycerol-3-phosphate and adenosine diphosphate. 
Glycerol-3-phosphate is then oxidized by glycerophosphate 
oxidase to form dihydroxyacetone phosphate and hydrogen 
peroxide. A pink chromogen complex, quinoneimine, is 
produced by a peroxidase catalyzed coupling of 4-
aminoantipyrine and phenol with the hydrogen peroxide, and 
this is proportional to the concentration of triglyceride in the 
sample.  
Briefly, to 0.01ml of sample (plasma/HDL) was added 1.0ml 
of the cholesterol/triglyceride kit reagent, and incubated for 
10 minutes after which absorbance was read at 505nm with a 
spectrophotometer. Total phospholipids in plasma/HDL were 
extracted with chloroform-methanol mixture (2:1, v/v) as 
described by Folch et al. (1957). Phospholipid concentration 
was then assessed with ammonium ferrothiocyanate by the 
method of Stewart (1980). The method is based on complex 
formation between ammonium ferrothiocyanate and 
phospholipids. It allows for phospholipid measurement in the 
range of 0.01 - 0.10mg (15 - 150nmol). An aliquot of the 
extract (0.1 ml) was evaporated to dryness at 60°C. After 
cooling, 2 ml of chloroform was added to the dried extract, 
mixed and 2 ml of ammonium ferrothiocyanate was then 
added and then mixed for 1 min. The mixture was left for 10 
min for separation to occur. The chloroform layer was then 
taken and the absorbance read at 488 nm. Phospholipid 
concentrations were determined using a phospholipid 
standard as reference. 
Organ, VLDL+LDL and erythrocyte lipid profiles 
Lipids were extracted from erythrocytes using the method of 
Rose and Oklander (1965) and from the organs (liver, kidney, 
heart, testes and brain) and VLDL+LDL as described by 
Folch et al. (1957). Homogenates of the organs (10%) were 
prepared in choloroform-methanol (2:1v/v) mixture. The 
mixtures were then centrifuged at 4000rpm for 10 minutes 
and the supernatants containing the lipid were removed into 
clean Eppendorf tubes. After washing the extracts with 0.05M 
KCl solution, aliquots of the extracts (0.1ml) were then used 
for the determination of cholesterol, triglycerides and 
phospholipid concentrations as described by Ugbaja et al. 
(2013a, b). Briefly, for cholesterol determination, 0.1 ml of the 
extract was evaporated to dryness at 60oC and 20µl of Triton 
X-100/chloroform mixture (1:1, v/v) was added to the dried 
extract for resolution. This was evaporated again and then 1 
ml of the cholesterol kit reagent was added, mixed and 
incubated for 30 minutes before reading the absorbance at 
505nm in a spectrophotometer. For triglyceride 
determination, 0.1ml of extract was evaporated to dryness 
and 0.1 ml of 97% ethanol was added to re-suspend the dried 
lipid. To this, 1 ml of the triglyceride kit reagent was added, 
mixed and incubated for 30 minutes before absorbance was 
read. For phospholipid determination however, the method of 
Stewart (1980) was employed.  
Statistical analysis 
The results obtained are expressed as mean ± SD. One-way 
analysis of variance (ANOVA) followed by Tukey’s test was 
used to analyze the results. Values with p<0.05 were 
regarded as significant using the Statistical Package for 




Table 1 shows the effect of the treatments on plasma and 
erythrocyte lipid profiles. While significant increases (p<0.05) 
were observed in the plasma levels of cholesterol (50%) and 
triglyceride (30%), significant decreases of 42% and 21% 
were observed in the erythrocyte compared with control. A 
decrease (p<0.05) of 40% was however observed in plasma 
phospholipid level while it increased by 37% in the 
erythrocyte when compared with control. On the part of the 
antioxidants, they did not cause a significant (p>0.05) 
perturbation in the plasma and erythrocyte rather they 
attenuated the effects of Al in the compartments. Vitamin E 
proved to be a better agent against the effect of Al than 
vitamin C, though not significantly (p<0.05).   
 
 
Table 1: Plasma and erythrocyte lipid profiles (mg/dl) of animals 
in the different treatment groups. 
	  
Values are mean ± SD (n=6). Values having different superscripts 
are significantly different from one another at p<0.05 
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Table 2: HDL and VLDL+LDL lipid profiles (mg/dl) of animals in 
the different treatment groups. 
 
	  
Values are mean ± SD (n=6). Values having different superscripts 







Table 3: Brain and heart lipid profiles (mg/g tissue) of animals in 
the different treatment groups. 
 
	  
Values are mean ± SD (n=6). Values having different superscripts 






Figure 1: Liver HMG CoA: mevalonate ratio as an index of HMG 
CoA reductase activity. Each bar represents mean ± SD (n=6). 
Bars with different alphabets are significantly different at p<0.05. (1= 
Control, 2 = AlCl3, 3 = Vitamin C, 4 =Vitamin E, 5 = AlCl3  + Vitamin 







Table 2 depicts the effect of the treatments on HDL and 
VLDL+LDL lipid profiles. Only cholesterol level was affected 
in HDL. Al intoxication affected a 29% decrease in the 
reverse cholesterol transport compared with control. The 
effect on VLDL-LDL was very similar to what was observed in 
the plasma. Al intoxication resulted in 35% and 30% 
significant increases in cholesterol and triglyceride level 
respectively while reducing the VLDL+LDL phospholipid level 
by 17% compared with control. The two antioxidants 
attenuated the effects of Al in these lipoprotein fractions to 
almost the same levels which were not significantly different 
(p>0.05) from the other even compared with control.  
Tables 3 and 4 show the effects of the treatments on the 
organs. Triglyceride level in the Al administered group was 
increased significantly (p<0.05) by 13% and 26% in the liver 
and brain respectively while it was not perturbed in the heart, 
testis and kidney compared with control. Cholesterol level 
was however only increased in the heart, liver and brain of 
the Al intoxicated group by 79%, 49% and 41% respectively 
and decreased by 52% in the testis compared with control. In 
all the organ compartments, only the brain phospholipid level 
was significantly (p<0.05) altered by a 35% decrease in 
comparison with control. Vitamins C and E prevented the 
effects of Al in the organs of the animals as observed by the 
insignificant differences (p>0.05) of the levels of the lipids. 
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However, in the brain, the antioxidants were unable to 
effectively attenuate the decreased phospholipid level as the 
resultant levels were still significantly different (p<0.05) from 
the control.   
Figure 1 shows the effect of the treatments on liver HMG 
CoA: mevalonate ratio as an index of HMG CoA reductase 
activity. An increase in this ratio signifies an inhibition of 
cholesterogenesis while a decrease indicates enhanced 
cholesterogenesis. HMG CoA reductase activity in the liver 
was significantly increased (p<0.05) at a rate of 23% in the 
Al-administered group compared with control. While the 
activity of the enzyme was not disrupted by the antioxidants 
(Figure 1), only vitamin C further significantly (p<0.05) 
inhibited cholesterogenesis by 42% from the Al induced level 
while vitamin E reversed the effect of Al to a non-significant 
activity compared with control.  
 
Table 4: Liver, kidney and testis lipid profiles (mg/g tissue) of 
animals in the different treatment groups. 
 
	  
Values are mean ± SD (n=6). Values having different superscripts 
are significantly different from one another at p<0.05.  
 
DISCUSSION  
Aluminum (Al) is known to be toxic to humans and animals. 
Its toxicity results to generation of reactive oxygen species 
which leads to oxidative damage of biomolecules in an 
organism (Shohda et al., 2001; Gonzalez et al., 2007; 
Newairy et al., 2009). Of these biomolecules are the lipids 
which play important roles in the body system whether in 
circulation or in organs. A lipid dystrophy which could be 
lipotoxic or non-lipotoxic could play a role in the pathogenesis 
or progression of a plethora of diseases. The present study 
investigated the effects of natural antioxidants against the 
harmful effects of AlCl3 in the blood and organ of rats.  
The findings of this study were that Al perturbed the 
metabolism of lipids (cholesterol, triglyceride and 
phospholipid) in different compartments in the organism. 
These perturbations were reflected in the up-/down-regulation 
of the levels of these lipids. This suggests that the 
metabolism of these lipids by their respective enzymes may 
have been up- or down-regulated due to exposure to Al. 
These perturbations were presented in the plasma as 
hypertriglyceridemia, hypercholesterolemia and 
hypophospholipidemia. The same trend was showcased in 
the VLDL+LDL fraction while only the reverse cholesterol 
transport mechanism indicated as HDL cholesterol, was 
significantly decreased. Also, the reverse of the effects of Al 
exposure in plasma was manifested in the erythrocyte while 
in the organs; cholesterogenesis was induced in the heart, 
liver and brain. A decreased cholesterol level was indicated in 
the testis. On the other hand, a dystrophy in the triglyceride 
level was presented in only the liver and brain. Treatments 
with the antioxidants (vitamin C and E) proved effective in 
reversing the effects of Al exposure in the various tissues.  
The increase in plasma cholesterol as a result of ingestion of 
aluminum agrees with the results of other researchers (El-
Demerdash, 2004; Fahid, 2009; Abdel Aziz and Zabut, 2011 
and John et al., 2015). This increase probably indicates a 
loss of membrane integrity (Sarin et al., 1997). This 
assumption of loss of membrane integrity as a result of Al has 
been confirmed by Newairy et al. (2009), where they reported 
Al significantly affecting various membrane-bound enzymes.  
HDL cholesterol of the animals administered with Al was 
decreased compared to other groups including the control. 
This agrees with the report of John et al. (2015). The 
decrease in the HDL cholesterol indicated that the reverse 
cholesterol transport is affected and presents a risk factor for 
cardiovascular disease, atherosclerosis and ischemia (a 
reduction in blood flow to the brain) (EL-Kholy et al., 2010). 
HDL is a lipoprotein which picks cholesterol from extrahepatic 
tissues to the liver for degradation (Murray et al., 2003). The 
decreased level of cholesterol with an observed concomitant 
increase in plasma cholesterol indicates the increase 
associated with the plasma is arising from the increased 
VLDL+LDL cholesterol level. LDL fraction of the VLDL+LDL 
takes up cholesterol from the liver (with 49% increase) to 
extrahepatic tissues hence the accumulation of cholesterol in 
heart and brain and not testis. The decreased cholesterol 
level observed in this study corroborates the findings of 
Kutlubay et al. (2007). Several mechanisms could be 
adduced for this; (1) Al ingestion probably caused a 
preferential activation of receptor sites on the cells of the 
heart and brain for the uptake of cholesterol but not the testis, 
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(2) Al could have favoured the synthesis of cholesterol in 
these organs apart from the testis by up-regulating 
hydroxymethylglutaryl coenzyme A reductase (a rate-limiting 
enzyme in cholesterol synthesis pathway) since virtually all 
cells can synthesize cholesterol (3) Al could have 
compromised the integrity of the cell membrane thereby 
causing a constipation of cholesterol in the organs by 
modification of the composition, structure and stability of the 
cell membranes, such that HDL could not pick up this lipid 
from these organs.   
The decreased level of cholesterol in the testis indicates that 
Al exposure could lead to a reproductive dysfunction and 
consequently infertility (Yousef et al., 2005). Al intoxication 
has been linked to various diseases like cardiovascular 
diseases (Young and Woodside, 2001). This is confirmed in 
this study as seen in increased levels of cholesterol in 
plasma, LDL and heart. 
In the erythrocytes, the levels of lipids were presented as a 
reverse of what is obtained in the plasma (Table 1). A major 
pathway for the replacement of erythrocyte lipids is through 
exchange with plasma lipoproteins (Czarnecka and 
Yokoyama, 1996). Nikolic et al. (2007) reported that there is a 
rapid exchange of lipids between the HDL fraction and 
erythrocytes and that HDL cholesterol may be a determinant 
factor in the lifespan of erythrocytes. Decreased HDL 
cholesterol was observed in this study. Our result is in line 
with this report as the same pattern of decreased cholesterol 
level was observed in these two compartments.  
Al exposure resulted in increased triglyceride levels in the 
plasma. This is in agreement with the findings of El-
Demerdash (2004), Abdel Aziz and Zabut (2011) and John et 
al. (2015). VLDL-LDL fraction had an increased level of 
triglyceride. The major lipid in VLDL is triglyceride which is 
endogenously synthesized by the liver. Contrary to expected 
result for liver triglyceride level, a decrease was observed. 
This result could not be elucidated as yet, but it could be 
considered thus; that the membranes of the cells have 
actually been compromised such that a leakage of the lipid 
ensued from the organ into the extracellular pool giving rise 
to one of the cardiovascular risk factor (hypertriglyceridemia). 
The increased levels of VLDL and LDL (ß-lipoproteins) in Al 
treated rats have been shown to be cytotoxic to cells and 
tissue, presumably due to enhanced levels of associated lipid 
peroxidation (Zenker et al., 1986). Previous study reported 
that during hyperlipemia, cell injury and lipid accumulation 
may result so as to initiate and maintain atheromatous 
lesions by lipoprotein (Harker et al., 1976). 
A decrease in the level of phospholipid which is in 
accordance with the results of Yousef (2004) was observed. 
Al has high affinity for phosphate group and binds to the 
phospholipid head groups using electrostatic force disturbing 
the dynamic parameters of the lipid bilayer (Martin, 
1986).This resulted to a decrease in VLDL+LDL phospholipid 
level, implying that Al induced a failure in hepatic provision of 
phospholipid in the lipoprotein (Murray et al., 2003). This 
could also be the reason why the brain also had a decreased 
level of phospholipid.  
This report demonstrated that there was no significant 
difference in the total lipids in the blood and organs of albino 
rats administered Al and supplemented with vitamin E and 
vitamin C indicating that the two antioxidant vitamins could 
attenuate the effects of exposure to Al. This is in accordance 
with the reports of Ithayarasi and Devi (1997), Chinoy and 
Memon (2001), El-Demerdash (2004), Yousef et al. (2005), 
Kutlubay et al. (2007) and Atef (2011) but disagrees with that 
of Abdel Aziz and Zabut (2011). The difference in the results 
could be to the dose of supplement administered. While they 
administered 150mg/kg body weight to the rats, we 
administered 200mg/kg body weight.  While a lot of 
researches abound for vitamin E in Al intoxication studies, a 
paucity of literature is found for vitamin C in this metal study. 
Al has been proved to alter the oxidant status in organisms 
(Abubakar et al., 2003). Vitamin C as an antioxidant could 
prevent Al from forming lipid peroxidation products or once 
formed, scavenge them a render the harmless in the 
organism (Onunkwor et al., 2004). Vitamin E on the other 
hand, allows free radicals to abstract hydrogen from its 
molecule rather than from the polyunsaturated fatty acids, 
thus breaking the chain of free radical reactions (Pascoe et 
al., 1987) and neutralizing lipid peroxidation and unsaturated 
membrane lipids (Aldana et al., 2001; Tuiguta et al., 2006). 
This therefore maintains the structure and functional integrity 
of the membrane.  
In conclusion, the present study demonstrated that oral 
administration of AlCl3 at a dose of 20 mg/kg daily for 28 days 
caused a dystrophy in lipid in blood and organs. 
Administration of vitamins C and E at doses of 200mg/kg 
each tended to minimize the effects of Aluminium. Hence, 
supplementation with these vitamins may be useful as 
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